F2G raised a $100m round co-led AMR Action Fund and ICG, joined by Novo, Advent Life, Sofinnova, Forbion, Blue Owl, Morningside, and Merifin Capital.

Round investors: Advent Life Sciences Morningside Ventures Forbion Capital Partners Novo A/S Sofinnova Partners Intermediate Capital Group AMR Action Fund Blue Owl Capital Merifin Capital Brace Pharma Capital